| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abbvie Inc. (ABBV) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 79 sells. ABBV is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 177.3K | $38.38M | - | |
| VP | 68.3K | $14.79M | - | |
| Dir | 28.5K | $6.17M | - | |
| Dir | 10.3K | $2.22M | - | |
| Dir | 707 | $153.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 | Saleki-Gerhardt Azita | SVP, Operations | Sale+OE | 8,300 | $85.02 | $705,655.44 | -1.9% | |
| Aug 7, 2017 | Gonzalez Richard A45 | Chairman Of The Board And CEO | Sale+OE | 193,131 | $71.00 | $13,713,185.64 | -3.6% | |
| Aug 4, 2017 | Gonzalez Richard A45 | Chairman Of The Board And CEO | Sale+OE | 87,899 | $71.02 | $6,242,297.49 | -3.3% | |
| Jul 31, 2017 | Gosebruch Henry O53 | Chief Strategy Officer | Sell | 300 | $70.42 | $21,127.00 | -0.2% | |
| Jul 31, 2017 | Gosebruch Henry O53 | Chief Strategy Officer | Sell | 18,000 | $70.09 | $1,261,638.37 | -0.7% | |
| Jul 31, 2017 | Rapp Edward J | Director | Buy | 4,000 | $70.45 | $281,782.00 | +34.8% | |
| Jun 14, 2017 | Alban Carlos | EVP, Commercial Operations | Sale+OE | 45,800 | $70.00 | $3,206,000.00 | -28.5% | |
| Jun 14, 2017 | Schumacher Laura J | Executive Vice President | Sale+OE | 79,800 | $70.00 | $5,586,000.00 | -42.5% | |
| May 19, 2017 | Gonzalez Richard A45 | Chairman Of The Board And CEO | Sell | 71,235 | $65.49 | $4,665,062.99 | -1.3% | |
| May 18, 2017 | Chase William J | EVP, Chief Financial Officer | Sale+OE | 38,300 | $65.35 | $2,502,905.00 | -17.3% |